InvestSMART

CurveBeam AI Limited (ASX: CVB) - Announcements

- Current share price for CVB : $0.020

ASX company news and announcements for CurveBeam AI Limited (CVB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All CurveBeam AI Limited (CVB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than CurveBeam AI Limited (CVB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for CurveBeam AI Limited (CVB)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$17 Initial Director's Interest Notice - Dan Pryor 26 Oct 2026 9:44AM $0.021 $0.020 fallen by 4.76%
$17 Notification regarding unquoted securities - CVB 26 Oct 2026 9:00AM $0.021 $0.020 fallen by 4.76%
$17 Director Appointment - Dan Pryor NED & ARC Chair 26 Oct 2026 8:36AM $0.021 $0.020 fallen by 4.76%
$17 CVB Quarterly Investor Presentation - Q1 FY27 21 Oct 2026 8:26AM $0.018 $0.020 risen by 11.11%
$17 Quarterly Activities/Appendix 4C Cash Flow Report 21 Oct 2026 8:26AM $0.018 $0.020 risen by 11.11%
$17 Q1 FY27 Quarterly Results Investor Webinar 16 Oct 2026 12:11PM $0.022 $0.020 fallen by 9.09%
$17 Change in substantial holding - Intellivision Holdings 13 Oct 2026 5:35PM $0.023 $0.020 fallen by 13.04%
$17 Change in substantial holding - Arun & Susmita Singh 13 Oct 2026 4:16PM $0.023 $0.020 fallen by 13.04%
$17 CVB Achieves NMPA Approval for HiRise in China 13 Oct 2026 9:17AM $0.020 $0.020 fallen by 0%
$17 Trading Halt 12 Oct 2026 9:53AM $0.020 $0.020 fallen by 0%
$17 Cleaning Notice for Shortfall Overflow Placement - Part B 9 Oct 2026 12:04PM $0.020 $0.020 fallen by 0%
$17 Notification regarding unquoted securities - CVB 9 Oct 2026 12:02PM $0.020 $0.020 fallen by 0%
$17 Application for quotation of securities - CVB 9 Oct 2026 11:50AM $0.020 $0.020 fallen by 0%
$17 Date of 2026 Annual General Meeting 2 Oct 2026 12:32PM $0.021 $0.020 fallen by 4.76%
$17 Cleansing Notice for Shortfall Overflow Placement 30 Sep 2026 5:12PM $0.023 $0.020 fallen by 13.04%
$17 Application for quotation of securities - CVB 30 Sep 2026 4:55PM $0.023 $0.020 fallen by 13.04%
$17 Application for quotation of securities - CVB 30 Sep 2026 4:27PM $0.023 $0.020 fallen by 13.04%
$17 Ceasing to be a substantial holder 29 Sep 2026 6:00PM $0.023 $0.020 fallen by 13.04%
$17 Ceasing to be a substantial holder 29 Sep 2026 4:02PM $0.023 $0.020 fallen by 13.04%
$17 Application for quotation of securities - CVB 25 Sep 2026 9:11AM $0.025 $0.020 fallen by 20%
$17 Application for quotation of securities - CVB 23 Sep 2026 4:08PM $0.030 $0.020 fallen by 33.33%
$17 Proposed issue of securities - CVB 18 Sep 2026 9:22AM $0.032 $0.020 fallen by 37.50%
$17 Update - Proposed issue of securities - CVB 18 Sep 2026 9:11AM $0.032 $0.020 fallen by 37.50%
$17 Oversubscribed Shortfall Offer & Placement raise 1.75m 18 Sep 2026 9:00AM $0.032 $0.020 fallen by 37.50%
$17 FDA 510(k) Clearance CT-based BMD Technology 15 Sep 2026 8:17AM $0.020 $0.020 fallen by 0%

1 - 25 of 339 results

Page 1 of 14

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.